BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

766 related articles for article (PubMed ID: 17051250)

  • 1. Use of herpes simplex virus type 1-based amplicon vector for delivery of small interfering RNA.
    Sabbioni S; Callegari E; Manservigi M; Argnani R; Corallini A; Negrini M; Manservigi R
    Gene Ther; 2007 Mar; 14(5):459-64. PubMed ID: 17051250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticancer activity of an adenoviral vector expressing short hairpin RNA against BK virus T-ag.
    Sabbioni S; Callegari E; Spizzo R; Veronese A; Altavilla G; Corallini A; Negrini M
    Cancer Gene Ther; 2007 Mar; 14(3):297-305. PubMed ID: 17218949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of adeno-associated viral vector for delivery of small interfering RNA.
    Tomar RS; Matta H; Chaudhary PM
    Oncogene; 2003 Aug; 22(36):5712-5. PubMed ID: 12944921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effective inhibition of hepatitis B virus replication by small interfering RNAs expressed from human foamy virus vectors.
    Sun Y; Li Z; Li L; Li J; Liu X; Li W
    Int J Mol Med; 2007 Apr; 19(4):705-11. PubMed ID: 17334648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Herpes simplex virus type-1 amplicon vectors for vaccine generation in acute lymphoblastic leukemia.
    Zibert A; Thomassen A; Müller L; Nguyen L; Glouchkova L; Fraefel C; Roskrow M; Meisel R; Dilloo D
    Gene Ther; 2005 Dec; 12(23):1707-17. PubMed ID: 16034459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delivery of RNA interference to peripheral neurons in vivo using herpes simplex virus.
    Anesti AM
    Methods Mol Biol; 2010; 617():347-61. PubMed ID: 20336434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of recombinant adeno-associated virus vectors carrying small interfering RNA (shHec1)-mediated depletion of kinetochore Hec1 protein in tumor cells.
    Li L; Yang L; Scudiero DA; Miller SA; Yu ZX; Stukenberg PT; Shoemaker RH; Kotin RM
    Gene Ther; 2007 May; 14(10):814-27. PubMed ID: 17330085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HSV-1 amplicon-mediated post-transcriptional inhibition of Rad51 sensitizes human glioma cells to ionizing radiation.
    Saydam O; Saydam N; Glauser DL; Pruschy M; Dinh-Van V; Hilbe M; Jacobs AH; Ackermann M; Fraefel C
    Gene Ther; 2007 Aug; 14(15):1143-51. PubMed ID: 17495946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Herpes simplex virus 1 amplicon vector-mediated siRNA targeting epidermal growth factor receptor inhibits growth of human glioma cells in vivo.
    Saydam O; Glauser DL; Heid I; Turkeri G; Hilbe M; Jacobs AH; Ackermann M; Fraefel C
    Mol Ther; 2005 Nov; 12(5):803-12. PubMed ID: 16112910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integration of active human beta-galactosidase gene (100 kb) into genome using HSV/AAV amplicon vector.
    Oehmig A; Cortés ML; Perry KF; Sena-Esteves M; Fraefel C; Breakefield XO
    Gene Ther; 2007 Jul; 14(14):1078-91. PubMed ID: 17460718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A plasmid-based system for expressing small interfering RNA libraries in mammalian cells.
    Kaykas A; Moon RT
    BMC Cell Biol; 2004 Apr; 5():16. PubMed ID: 15119963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retroviral delivery of small interfering RNA into primary cells.
    Barton GM; Medzhitov R
    Proc Natl Acad Sci U S A; 2002 Nov; 99(23):14943-5. PubMed ID: 12417750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atelocollagen-mediated synthetic small interfering RNA delivery for effective gene silencing in vitro and in vivo.
    Minakuchi Y; Takeshita F; Kosaka N; Sasaki H; Yamamoto Y; Kouno M; Honma K; Nagahara S; Hanai K; Sano A; Kato T; Terada M; Ochiya T
    Nucleic Acids Res; 2004 Jul; 32(13):e109. PubMed ID: 15272050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction of simple and efficient DNA vector-based short hairpin RNA expression systems for specific gene silencing in mammalian cells.
    Cheng TL; Chang WT
    Methods Mol Biol; 2007; 408():223-41. PubMed ID: 18314586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor activity of an oncolytic adenovirus-delivered oncogene small interfering RNA.
    Zhang YA; Nemunaitis J; Samuel SK; Chen P; Shen Y; Tong AW
    Cancer Res; 2006 Oct; 66(19):9736-43. PubMed ID: 17018633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lentiviral siRNAs targeting multiple highly conserved RNA sequences of human immunodeficiency virus type 1.
    Chang LJ; Liu X; He J
    Gene Ther; 2005 Jul; 12(14):1133-44. PubMed ID: 15750613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted transgene integration into transgenic mouse fibroblasts carrying the full-length human AAVS1 locus mediated by HSV/AAV rep(+) hybrid amplicon vector.
    Bakowska JC; Di Maria MV; Camp SM; Wang Y; Allen PD; Breakefield XO
    Gene Ther; 2003 Sep; 10(19):1691-702. PubMed ID: 12923568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RNAi expression vectors in mammalian cells.
    Miyagishi M; Taira K
    Methods Mol Biol; 2004; 252():483-91. PubMed ID: 15017073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RNA interference mediated in human primary cells via recombinant baculoviral vectors.
    Nicholson LJ; Philippe M; Paine AJ; Mann DA; Dolphin CT
    Mol Ther; 2005 Apr; 11(4):638-44. PubMed ID: 15771966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vectors for RNA interference.
    Wadhwa R; Kaul SC; Miyagishi M; Taira K
    Curr Opin Mol Ther; 2004 Aug; 6(4):367-72. PubMed ID: 15468595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.